ArticleJACC. Advances2025
Clinical and Engagement Results of a Nationwide Comprehensive Remote Patient Care Hypertension Program.
Article in JACC. Advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Impact of a Remote Patient Care Program on Health Care Costs and Utilization Among Medicare Patients With Chronic Disease.Mayo Clinic proceedings. Innovations, quality & outcomes · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTraditional methods for treating hypertension have been ineffective. Remote patient care (RPC) can transform how we provide longitudinal care for patients with hypertension.
objectivesThe purpose of this study was to determine whether an RPC hypertension program can provide a scalable solution for optimizing hypertension management, especially among rural/underserved patients.
methodsA technology-enabled RPC provider enrolled patients into an RPC hypertension program from February 2022 to June 2024. Using vitals automatically transmitted from a cellular-enabled blood pressure (BP) cuff and scheduled visits, clinicians leveraged technology-enabled clinical protocols to drive engagement and improve hypertension control. Mean reduction in BP and percentage of individuals at BP goal were evaluated using a paired t-test and McNemar's test, respectively.
resultsA total of 23,638 patients were enrolled (mean [SD] age 73(9), 60.0% female, 56.9% rural/underserved) with a baseline BP of 140/81 mm Hg. The mean (SD) reduction in BP was 7/5 (14/8) mm Hg (P < 0.001) after a follow-up of 30 (24) weeks, with a greater reduction in individuals with a higher baseline BP. Clinical engagement was high (75% and 57% of patients still measuring vitals at 6 and 12 months, respectively) with 11,834,837 vitals measured, 177,620 clinical encounters and 118,792 phone calls completed, and 117,457 high-acuity clinical alerts resolved. There was a 70% relative increase in the number of patients at goal BP at follow-up (36.6% vs 21.5%; P < 0.001). Results among rural/underserved patients were similar.
conclusionsA nationwide RPC hypertension program can drive high patient engagement and facilitate clinical encounters at scale, resulting in reduced BP levels and more patients achieving BP goals across the United States.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.